CRSP — Put-Selling Research

by ThetaLoop Research
Skip to content
← Back to search
Last close:
CRISPR Therapeutics AG
Healthcare · $39.1
4.4
/10
Neutral
↑ +2.2 today
Put-selling entry timing — not a quality rating.
How this score works → Try the calculator ↓
Regime
Bearish
vs SMA200
SMA200 Distance
-25.2%
Below trend
Volatility
Normal
Average premiums
Momentum
Turning
4th day
About CRISPR Therapeutics AG
A gene-editing biotech behind the first approved CRISPR therapy (Casgevy for sickle cell disease). No dividend, high beta (~1.3). Binary event risk around pipeline catalysts and regulatory milestones. Rich premiums reflect biotech uncertainty — CSP sellers must be comfortable with sudden, outsized moves.
Biotechnology
Market Cap
$3.8B
P/E Ratio
—
Beta
1.90
Forward P/E
-10.6
52-Week Range Current: $39.1
$38.18 $63.45

CRSP — at the 4th percentile of the yearly range, premium quality and downside exposure move together. Historical base-rates show sizing discipline mattering more than premium chasing in this configuration.

Based on end-of-day market dataScored by ThetaLoop Research
CRSP ranks #2 of 66 Healthcare tickers by put-selling score (612 total screened)

Position Size & Yield Calculator

Live model for CRSP — drag any slider to recalculate. Strike defaults to ~5% OTM, snapped to typical exchange increments.
$
$
$
days
0
max fully-secured contracts
Capital per Contract0%
$0 —
Premium Income
$0
per contract
Per-Day Theta
$0.00
if held to expiration
Annualized ROC
0.0%
return on collateral
📈At this pace: $0/year per contract if you roll continuously every 30 days
Calculator assumptions

Cash-secured puts require holding cash equal to strike × 100 shares as collateral. Strike defaults to ~5% OTM, snapped to typical exchange increments. Premium defaults to ~2% of strike — adjust to your real expected fill. Annualized ROC = (premium ÷ collateral) × (365 ÷ DTE). CSP risk is single-name concentration: experienced put-sellers typically diversify across 4–6 underlyings rather than committing the whole account to one ticker. Continuous-rolling projections assume capital can be re-deployed after each expiration and that comparable premiums remain available — actual results vary with market conditions, assignments, and rolls.

This page is the research tool — you search any ticker, get the score, configure your own setup. The daily research publishes setups that pass the nightly filters, with strike, expiry, profit-capture references, and a tracking framework. Not every ticker, not every day. Quiet days are quiet. See a sample · how the pipeline works
More Healthcare Research
ABBV AbbVie Inc. 5.5 CLOV Clover Health Investments, Corp. 4.4 BIIB Biogen Inc. 3.9 INO Inovio Pharmaceuticals, Inc. 3.5 MRK Merck & Co., Inc. 3.3 Browse all Healthcare tickers →
📌 Embed this score on your blog
The CRSP X-Ray score updates daily after market close. Embed it on any site, blog, or trading journal — completely free, no API key needed. The visible attribution line below the widget links back to ThetaLoop and helps the project grow.
<iframe src="https://thetaloop.app/widget/xray/CRSP" width="400" height="460" frameborder="0" loading="lazy"></iframe> <p style="text-align:center;font-size:11px;margin-top:6px;font-family:sans-serif"><a href="https://thetaloop.app/xray/CRSP">CRSP X-Ray Score</a> by ThetaLoop</p>
Live preview: Open widget in new tab →
When setups pass our filters, see the full research format. See how daily research works →
📊 Public Trade Ledger — All Recorded Closed Outcomes
Cash-Secured Put ledger ↗ · See a sample →